Browse the detailed record of transactions filed by Whitley Richard James, Director. Insider active across 2 companies, notably Gilead Sciences INC. In total, 9 filings have been logged. Total volume traded: €22k. The latest transaction was disclosed on 18 May 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Richard James Whitley is a Board Member at Gilead Sciences Inc and Virios Therapeutics, Inc. He has significant experience in the biopharmaceutical sector. As a board member, he is involved in overseeing operations and strategic decision-making. His expertise in life sciences is valuable in guiding these companies towards sustainable growth.